- Home
- IMMP vs AMPY Comparison
IMMP vs AMPY Comparison
Compare IMMP & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- AMPY
- Stock Information
- Founded
- IMMP 1987
- AMPY 2011
- Country
- IMMP Australia
- AMPY United States
- Employees
- IMMP N/A
- AMPY N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- AMPY Oil & Gas Production
- Sector
- IMMP Health Care
- AMPY Energy
- Exchange
- IMMP Nasdaq
- AMPY Nasdaq
- Market Cap
- IMMP 251.8M
- AMPY 203.1M
- IPO Year
- IMMP N/A
- AMPY 2011
- Fundamental
- Price
- IMMP $1.97
- AMPY $4.88
- Analyst Decision
- IMMP Buy
- AMPY Strong Buy
- Analyst Count
- IMMP 1
- AMPY 1
- Target Price
- IMMP $7.00
- AMPY $11.00
- AVG Volume (30 Days)
- IMMP 120.6K
- AMPY 2.2M
- Earning Date
- IMMP 10-10-2025
- AMPY 11-05-2025
- Dividend Yield
- IMMP N/A
- AMPY N/A
- EPS Growth
- IMMP N/A
- AMPY N/A
- EPS
- IMMP N/A
- AMPY 0.38
- Revenue
- IMMP $3,306,742.00
- AMPY $279,289,100.00
- Revenue This Year
- IMMP $16.82
- AMPY $1.83
- Revenue Next Year
- IMMP N/A
- AMPY N/A
- P/E Ratio
- IMMP N/A
- AMPY $13.83
- Revenue Growth
- IMMP 31.28
- AMPY N/A
- 52 Week Low
- IMMP $1.32
- AMPY $2.27
- 52 Week High
- IMMP $2.71
- AMPY $7.23
- Technical
- Relative Strength Index (RSI)
- IMMP 63.51
- AMPY 51.32
- Support Level
- IMMP $1.75
- AMPY $4.86
- Resistance Level
- IMMP $2.10
- AMPY $5.44
- Average True Range (ATR)
- IMMP 0.09
- AMPY 0.41
- MACD
- IMMP 0.03
- AMPY -0.05
- Stochastic Oscillator
- IMMP 74.79
- AMPY 20.14
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.